IP and Access to Medicines

• Intellectual Property in the FTA: Impacts on Pharmaceutical Spending and Access to Medicines in Colombia
  
  
• Preliminary analysis of biologics exclusivity in the leaked Trans Pacific Partnership Agreement text
  
  
• Public Health at Risk: A US Free Trade Agreement could threaten access to medicines in Thailand
  
  
• Access To Medicines At Risk Across The Globe - What To Watch Out For MSF
  (1.86MB)
  
  
• CAFTA Side Letter Does Not Protect Access To Medicines
  
  
• Conclusion Asian Workshop On TRIPS and Access To Medicines
  
  
• Data Exclusivity In International Trade Agreements MSF
  
  
• Data Exclusivity Patents And Registration Of Medicines
  
  
• Declaration On The TRIPS Agreement And Public Health
  
  
• Flexibilities In WTOs TRIPS Agreement For Access To Medicines
  
  
• FTA Between The USA & Thailand Threatens Access To AIDS Treatment
  
  
• Impact of US - Thai FTA on Thai Drug System
  
  
• Imports By & Exports To Countries With Insufficient Or No Manufacturing Capacities In The Pharmaceutical Sector
  
  
• Lessons From The Latin American Experience (2.15MB)
  
  
• Malaysia's Experience In Increasing Access To Antiretroviral Drugs
  
  
• Patent Protection & Consideration Of Public Health In China
  
  
• Possible Impact Of Market Exclusivity Extension On Pharmaceuticals In Thailand
  
  
• Protection Of Data Submitted For The Registration Of Pharmaceuticals
  
  
• Statement By Senator Edward Kennedy To The US Senate
  
  
• Thai NGOs Appeal To UN On FTAs Effect On Health
  
  
• The Impact of US Thai FTA A Civil Society Perspective (1.94MB)
  
  
• The FTA Between Australia & the US
  
  
• Trade Agreements and Access to Medications Under The Bush Administration
  
  
• TRIPS + Provisions in FTAs And Implications For Access To Medicines
  
  
• TRIPS and Public Health WTO Submission
  
  
• Undermining Access To Medicines
  
  
• WHO Perspective on Medicine Patents & FTAs